Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call shows mixed results: modest revenue growth, improved EBITDA, and cost reductions are positive. However, gross margins declined, and the net loss persists. The Q&A reveals optimism about future margins and business expansion, but lacks concrete guidance on tariffs. The market reaction is likely neutral, balancing positive cost control and revenue growth against margin pressures and ongoing losses.
Net Sales $38.4 million, up 7.5% year-over-year from $35.7 million. Growth driven by the commercial B2B business.
Cultivation and Gardening Segment Sales $31.9 million, up from $30.9 million year-over-year. Proprietary brand sales represented 37% of revenue, up from 32% last year, driven by strategic initiatives to increase higher-margin proprietary products.
Storage Solutions Segment Sales $6.5 million, up 35.5% year-over-year from $4.8 million. Growth driven by increasing capital investment across broader end markets.
Gross Profit $9.7 million, consistent year-over-year. Decline in Cultivation and Gardening gross profit due to inventory-related charges and product mix, offset by a 42.7% increase in Storage Solutions gross profit.
Gross Margin 25.4%, down from 27.2% year-over-year. Decline due to store closures and higher mix of lower-margin durable products.
Store and Operating Expenses $6.4 million, down 27.2% year-over-year from $8.8 million. Reflects benefits of cost reduction initiatives.
Selling, General and Administrative Expenses $6.9 million, down 2.6% year-over-year from $7.1 million.
Total Operating Expenses $15 million, down 23.4% year-over-year from $19.6 million. Decrease driven by cost reduction initiatives.
Depreciation and Amortization $1.6 million, down 55.1% year-over-year from $3.6 million. Decrease due to asset retirements and certain intangible assets reaching end of useful lives.
GAAP Net Loss $4.9 million, improved by $4.5 million year-over-year from $9.4 million. Improvement driven by higher revenues, reduced operating expenses, and lower depreciation and amortization.
Non-GAAP Adjusted EBITDA Loss of $1.6 million, improved by $2.4 million year-over-year from a loss of $4 million. Improvement reflects cost reduction initiatives and improved operating leverage.
Cash, Cash Equivalents, and Marketable Securities $41.1 million, with no debt. Reflects focus on liquidity, working capital discipline, and inventory quality.
Proprietary Brand Sales: Proprietary brand sales represented 37% of Cultivation and Gardening revenue during the quarter, up from 32% in the prior year. This reflects progress in shifting sales mix towards higher-value recurring consumable proprietary branded products.
Storage Solutions Segment: Revenue increased 35.5% year-over-year, driven by increasing capital investment activity across a broader range of end markets.
Commercial B2B Platform Expansion: GrowGeneration expanded relationships with multistate operators, greenhouse growers, and other commercial cultivation customers across North America through GrowGen.Pro.
International Expansion: The company expanded its commercial presence in Canada and advanced additional international distribution relationships.
Cost Reduction Initiatives: Store and other operating expenses declined by approximately 27.2% year-over-year, reflecting benefits from cost reduction initiatives.
Operating Efficiency: Total operating expenses decreased by 23.4% year-over-year, driven by cost reduction initiatives and improved operating leverage.
Focus on Proprietary Brands: The company is expanding proprietary brands into adjacent channels and new customer categories, including lawn and garden channels through online big box retail and direct-to-consumer platforms.
Regulatory Environment Impact: The reclassification of state-licensed medical cannabis to Schedule III of the Controlled Substances Act provides tax relief to operators, potentially increasing their capacity to invest in cultivation infrastructure.
Gross Margins: Gross margins were impacted by factors related to store consolidation activity and product mix during the quarter, which are expected to be short-term pressures.
Store Closures: Inventory-related charges from 4 store closures negatively impacted gross profit in the Cultivation and Gardening segment.
Product Mix: A higher mix of lower-margin durable products in the Cultivation and Gardening segment contributed to a decline in gross profit.
Regulatory Environment: The regulatory process for moving state-licensed medical cannabis to Schedule III of the Controlled Substances Act is ongoing, which could impact customer investment capacity and industry dynamics.
Revenue Guidance for Q2 2026: Expected revenue in the range of $42 million to $44 million, along with a return to positive adjusted EBITDA.
Full Year 2026 Revenue and EBITDA Guidance: Net revenue expected in the range of $162 million to $168 million with approximately breakeven adjusted EBITDA.
Proprietary Brand Penetration Target: Aiming to expand proprietary brand penetration towards approximately 40% by year-end 2026.
Gross Margin Outlook: Expecting improving gross margins as the year progresses, supported by cost reduction initiatives and operating leverage.
Market Trends and Regulatory Environment: The reclassification of state-licensed medical cannabis to Schedule III is expected to provide financial relief to customers, potentially increasing their capacity to invest in cultivation infrastructure.
Share Repurchase Program: During the first quarter, the Board of Directors authorized a share repurchase program of up to $10 million of the company's outstanding common stock. The program will be executed opportunistically, subject to market conditions, capital allocation priorities, and applicable securities laws.
The earnings call shows mixed results: modest revenue growth, improved EBITDA, and cost reductions are positive. However, gross margins declined, and the net loss persists. The Q&A reveals optimism about future margins and business expansion, but lacks concrete guidance on tariffs. The market reaction is likely neutral, balancing positive cost control and revenue growth against margin pressures and ongoing losses.
The earnings call reveals a strategic shift towards higher-margin proprietary brands and a focus on B2B operations, leading to improved margins and reduced losses. The share repurchase program indicates confidence in future prospects, while cash reserves and no debt offer financial flexibility. Despite sales decline, margin improvements and cost reductions are notable. The Q&A highlights strategic diversification and operational focus, though some details remain vague. Overall, the positive elements, including the share buyback and margin gains, outweigh negatives, suggesting a likely stock price increase of 2% to 8%.
The company's financial performance shows improvement in gross margins and EBITDA profitability, despite a net loss. Proprietary brand sales are strong, and cost reduction initiatives are effective. The Q&A section reveals optimistic guidance and clear communication from management. Risks include international expansion and supply chain disruptions, but the strong balance sheet and strategic focus on proprietary brands suggest a positive outlook. The absence of full-year guidance is a concern but offset by expected revenue growth. Overall, the sentiment is positive, suggesting a stock price increase of 2% to 8% over the next two weeks.
The earnings call reveals positive momentum, with improved proprietary product sales, gross margins, and reduced expenses. The Viagrow acquisition and strategic focus on private labels show growth potential. The Q&A highlights optimism in the gardening space, despite some uncertainties in repositioning and tariff impacts. The absence of debt and strong liquidity are additional positives. However, the lack of full-year guidance and ongoing net losses temper the outlook slightly, resulting in a positive sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.